Related Experiment Video
Updated: Dec 22, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.1K
A Qualitative Exploration to Understand Access to Pharmacy Medication Reviews: Views from Marginalized Patient Groups
Asam Latif1, Baguiasri Mandane1, Abid Ali1
1Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2UH, UK.
Pharmacy (Basel, Switzerland)
|May 3, 2020
Summary
Vulnerable patients face significant barriers accessing pharmacy services, impacting their health and medication reviews. Improving access requires addressing patient perceptions, seeking support, reaching pharmacies, and engagement for equitable healthcare.
Area of Science:
- Health Services Research
- Social Determinants of Health
- Pharmaceutical Services
Background:
- Marginalized groups, including people with disabilities, the homeless, and ethnic minorities, experience disproportionately worse health outcomes.
- These communities face challenges with healthcare access and low engagement in health screening services.
- The UK healthcare system prioritizes addressing these health disparities and ensuring equitable provision.
Purpose of the Study:
- To explore patient perspectives from marginalized groups on improving pharmacy service access.
- To understand their experiences with medication review services.
- To apply Levesque's access conceptual framework to analyze these experiences.
Main Methods:
- Qualitative study utilizing semi-structured interviews with patients from marginalized groups (n=10 for general pharmacy services, n=10 for medication reviews).
- Employed an interpretivist approach to analyze patient experiences.
- Focused on the 'demand-side' dimensions of Levesque's framework: perceiving need, seeking support, reaching pharmacy, ability to pay, and engagement.
Main Results:
- Vulnerable patients encounter substantial medicine, health, and social care challenges often inadequately addressed.
- Significant barriers exist in patients' ability to access and utilize pharmacy support services.
- The study highlights difficulties related to perceiving needs, seeking help, reaching facilities, affording services, and engaging with pharmacy care.
Conclusions:
- Pharmacy organizations must improve how patients perceive and seek pharmacy support, and enhance their ability to reach and engage with services.
- Community pharmacy staff require additional training to deliver accessible, inclusive, and culturally sensitive services.
- Policy changes are needed to reconfigure services, ensuring equitable access for diverse patient populations and promoting patient-centered care.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
162
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
162
01:02Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
01:19Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
01:12Analysis of Population Pharmacokinetic Data
606
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
606
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
104
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
104
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
95
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
95